Status Determination and Prioritization of Contraception Pipeline Products in Clinical Trials
National Institutes of Health · United States
Time Left to Bid
Awarded
Basic information
- Reference number
- 75N94019F00126
- Issuing organization
- National Institutes of Health · Find award history →
- Government level
- Federal
- Solicitation type
- Healthcare & Medical
- Title
- Status Determination and Prioritization of Contraception Pipeline Products in Clinical Trials
- Source
- USASpending (Federal)
- Source ID
- usa-75N94019F00126
Details
- Location
- United States
Summary
This is a delivery order task for status determination and prioritization of pipeline pharmaceutical products undergoing clinical trials for both male and female contraception. The work involves evaluating clinical trial progress, assessing product viability, and establishing prioritization criteria for contraceptive candidates in development. This supports the National Institutes of Health's research portfolio management.
Description
TASK ORDER 2: STATUS DETERMINATION AND PRIORITIZATION OF PIPELINE PRODUCTS UNDERGOING CLINICAL TRIALS FOR MALE AND FEMALE CONTRACEPTION Awarded to: HEALTH DECISIONS, INC. Agency: Department of Health and Human Services Sub-agency: National Institutes of Health Award type: DELIVERY ORDER
Dates
- Publication
- 2019/09/24 12:00:00 AM UTC
- Closing date
- 2028/12/31 12:00:00 AM UTC
Estimated value
$2.5M USD
Classification
Normalized category